MWNA
MJN

Marshall Wace North America’s Mead Johnson Nutrition Company MJN Stock Holding History

Marshall Wace North America’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,344,446
Closed -$120M – 1561
2017
Q1 		$120M Buy
+1,344,446
New +$111M 0.94% 15
2013
Q4 		$11.6M Buy
+138,331
New +$11.3M 0.25% 101

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Marshall Wace North America's MJN Position: Q2 2017 in Review

Marshall Wace North America sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,344,446 shares — an estimated $120M sold.

Marshall Wace North America first reported a position in MJN in Q4 2013 and held it in 2 quarters. The position peaked at $120M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Marshall Wace North America reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Marshall Wace North America sold 1,344,446 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $120M.
  • Marshall Wace North America first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 2 quarters.
  • Marshall Wace North America's Mead Johnson Nutrition Company position peaked at $120M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Marshall Wace North America's 13F filing for Q2 2017, filed 4 Aug 2017.